CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $101.65 billion. The enterprise value is $171.00 billion.
| Market Cap | 101.65B |
| Enterprise Value | 171.00B |
Important Dates
The last earnings date was Tuesday, February 10, 2026, before market open.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | Jan 22, 2026 |
Share Statistics
CVS Health has 1.27 billion shares outstanding. The number of shares has increased by 0.71% in one year.
| Current Share Class | 1.27B |
| Shares Outstanding | 1.27B |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 89.81% |
| Float | 1.27B |
Valuation Ratios
The trailing PE ratio is 57.48 and the forward PE ratio is 11.15. CVS Health's PEG ratio is 0.83.
| PE Ratio | 57.48 |
| Forward PE | 11.15 |
| PS Ratio | 0.25 |
| Forward PS | 0.25 |
| PB Ratio | 1.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.02 |
| P/OCF Ratio | 9.55 |
| PEG Ratio | 0.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.69, with an EV/FCF ratio of 21.90.
| EV / Earnings | 96.72 |
| EV / Sales | 0.43 |
| EV / EBITDA | 11.69 |
| EV / EBIT | 17.07 |
| EV / FCF | 21.90 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.06.
| Current Ratio | 0.84 |
| Quick Ratio | 0.57 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 4.53 |
| Debt / FCF | 10.24 |
| Interest Coverage | 3.21 |
Financial Efficiency
Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 5.62%.
| Return on Equity (ROE) | 2.29% |
| Return on Assets (ROA) | 2.47% |
| Return on Invested Capital (ROIC) | 5.62% |
| Return on Capital Employed (ROCE) | 6.08% |
| Weighted Average Cost of Capital (WACC) | 5.31% |
| Revenue Per Employee | $1.33M |
| Profits Per Employee | $5,893 |
| Employee Count | 300,000 |
| Asset Turnover | 1.58 |
| Inventory Turnover | 18.56 |
Taxes
In the past 12 months, CVS Health has paid $408.00 million in taxes.
| Income Tax | 408.00M |
| Effective Tax Rate | 19.10% |
Stock Price Statistics
The stock price has increased by +25.12% in the last 52 weeks. The beta is 0.50, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +25.12% |
| 50-Day Moving Average | 78.34 |
| 200-Day Moving Average | 73.03 |
| Relative Strength Index (RSI) | 56.85 |
| Average Volume (20 Days) | 8,626,110 |
Short Selling Information
The latest short interest is 16.53 million, so 1.30% of the outstanding shares have been sold short.
| Short Interest | 16.53M |
| Short Previous Month | 18.76M |
| Short % of Shares Out | 1.30% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 1.53 |
Income Statement
In the last 12 months, CVS Health had revenue of $399.83 billion and earned $1.77 billion in profits. Earnings per share was $1.39.
| Revenue | 399.83B |
| Gross Profit | 53.13B |
| Operating Income | 10.02B |
| Pretax Income | 2.14B |
| Net Income | 1.77B |
| EBITDA | 14.63B |
| EBIT | 10.02B |
| Earnings Per Share (EPS) | $1.39 |
Balance Sheet
The company has $10.60 billion in cash and $79.95 billion in debt, with a net cash position of -$69.35 billion or -$54.51 per share.
| Cash & Cash Equivalents | 10.60B |
| Total Debt | 79.95B |
| Net Cash | -69.35B |
| Net Cash Per Share | -$54.51 |
| Equity (Book Value) | 75.38B |
| Book Value Per Share | 59.18 |
| Working Capital | -13.98B |
Cash Flow
In the last 12 months, operating cash flow was $10.64 billion and capital expenditures -$2.83 billion, giving a free cash flow of $7.81 billion.
| Operating Cash Flow | 10.64B |
| Capital Expenditures | -2.83B |
| Free Cash Flow | 7.81B |
| FCF Per Share | $6.14 |
Margins
Gross margin is 13.29%, with operating and profit margins of 2.51% and 0.44%.
| Gross Margin | 13.29% |
| Operating Margin | 2.51% |
| Pretax Margin | 0.53% |
| Profit Margin | 0.44% |
| EBITDA Margin | 3.66% |
| EBIT Margin | 2.51% |
| FCF Margin | 1.95% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.33%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 191.37% |
| Buyback Yield | -0.71% |
| Shareholder Yield | 2.62% |
| Earnings Yield | 1.74% |
| FCF Yield | 7.68% |
Analyst Forecast
The average price target for CVS Health is $94.33, which is 18.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $94.33 |
| Price Target Difference | 18.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 4.48% |
| EPS Growth Forecast (5Y) | 49.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.27 |
| Piotroski F-Score | 7 |